Skip to main content

Partners Investment — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

79
Companies
$926.9M
Total invested
$16.6M
Avg. check
44
Industries
Biotechnology 10Health Care 8Artificial Intelligence (AI) 8Pharmaceutical 4Automotive 3Machine Learning 3+38 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 79
Senda Biosciences
August 2022

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

Biotechnology · Cambridge$123.0M Series C
Cellestia
June 2023

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

Biopharma · BaselNon-equity Assistance
AltPep
June 2023

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Biotechnology · Seattle$52.9M Series B
XBoost
April 2024

XBoost develops AI agents for online marketplace sellers and brands to automate their growth and operations with breakthrough innovation.

Artificial Intelligence (AI) · Los Angeles$8.6M Series A
Ring Therapeutics
March 2023

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

Biotechnology · Cambridge$86.5M Series C
Upstreet
March 2022

Mobile Share Rewards App

Consumer · Sydney$3.0M Seed
Sonde Health
February 2023

Sonde Health is a digital medicine company.

Biotechnology · BostonGrant
Phantom AI
February 2023

Phantom AI creates and delivers an advanced computer vision and related ADAS technology to automotive OEMs and Tier 1s.

Artificial Intelligence (AI) · Mountain View$41.5M Series C
Xpanner
June 2024

Xpanner(Builtworlds 2022 Top 50), digital contech site solution, bringing productivity improvement(15% average) through smart integration.

Construction · Seoul$10.8M Series B
Cytonus Therapeutics
November 2023

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

Biotechnology · Carlsbad$11.7M Series A
Medipixel
October 2023

Medipixel is a healthcare technology company that has created a number of AI-enhanced solutions for intervention surgeons.

Artificial Intelligence (AI) · Seoul$12.6M Series B
Endorobotics
August 2023

Endorobotics is a healthcare centre that offers endoscopic surgery services.

Health Care · Seoul$7.5M Series B
Adcentrx Therapeutics
April 2023

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

Biotechnology · San Diego$51.0M Series A
ALLO
December 2021

AI powered collaboration platform

Apps · San Francisco$5.0M Seed
Harbinger Health
January 2025

Harbinger Health is a biotechnology company that develops a two-tier testing model for the detection of early cancer with a blood test.

Artificial Intelligence (AI) · Cambridge$100.0M Venture - Series Unknown
Veritone
October 2025

Veritone is an AI company that offers machine learning models transforming data sources into actionable intelligence.

Artificial Intelligence (AI) · Irvine$75.0M Post-IPO Equity
BOS Semiconductors
February 2026

BOS Semiconductors develops semiconductor technology for the automotive industry.

Automotive · Seongnam$60.3M Series A
ASWEMAKE
December 2025

ASWEMAKE is a shopping app that delivers groceries.

Apps · IncheonSeries C
ENCell
December 2025

ENCell is a biotech company that develops and manufactures biopharmaceuticals.

Biotechnology · Seoul$15.3M Post Ipo Debt
Sionic AI
December 2025

Sionic AI is a technology company that allows users to design, manage, and utilize artificial intelligence in corporate environments.

Artificial Intelligence (AI) · Seoul$17.0M Series A
Okxe
July 2025

Okxe operates as an online marketplace for motorcycles.

Automotive · Hanoi$14.4M Series A
AIGEN Sciences
July 2025

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI) · SeoulSeries Unknown
LBox Co
June 2025

LBox is an information technology services and consulting company.

Artificial Intelligence (AI) · Seoul$21.8M Series C
Dime Bio
March 2025

Dime Bio is a drug development company for novel dementia treatments.

Medical · Seongnam$8.2M Series A

Where Partners Investment invests

Biotechnology10
Health Care8
Artificial Intelligence (AI)8
Pharmaceutical4
Automotive3
Machine Learning3

About Partners Investment's portfolio

How many companies has Partners Investment invested in?

Partners Investment has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Partners Investment invest in?

Partners Investment's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Pharmaceutical, Automotive. The firm invests across 44 different industry categories.

What is Partners Investment's largest investment?

Among tracked funding rounds, Senda Biosciences received $123.0M in a Series C round. Partners Investment's total known invested capital is $926.9M.

What is the average investment size for Partners Investment?

Partners Investment's average investment size is $16.6M across its portfolio of 79 companies.

What are Partners Investment's most recent investments?

Recent Partners Investment portfolio additions include Senda Biosciences, Cellestia, AltPep, XBoost, Ring Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 79 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →